Factors predicting the response to rituximab in indolent lymphoma

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma.

British journal of haematology·2024

Guidelines for composing and assessing a paper on the treatment of pain: A practical application of evidence-based medicine principles to a cost-effectiveness analysis of the MINT randomized clinical trials.

Interventional pain medicine·2024

Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro.

The AAPS journal·2024

Multicompartment imaging of the brain using a comprehensive MR imaging protocol.

NeuroImage·2024

Protocol to evaluate the effectiveness of a virtual-reality-based behavioral intervention in enhancing sensory responses to real-world warning.

STAR protocols·2024

Evaluation of artificial intelligence-powered screening for sexually transmitted infections-related skin lesions using clinical images and metadata.

BMC medicine·2024

Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.

Clinical lymphoma·2005

Activity of gallium nitrate in refractory peripheral T-cell lymphoma.

Clinical lymphoma·2005

Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.

Clinical lymphoma·2005

Long-term follow-up high-dose chemotherapy (drug-only program) followed by autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas.

Clinical lymphoma·2005

The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.

Clinical lymphoma·2005

Prognosis of follicular lymphomas.

Clinical lymphoma·2005

N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population.

Journal of virology·2026

Integrated Analysis of the STING1-IRF1 Signaling Pathway and Genomic Alterations in Breast Cancer: Implications for Immune Evasion and Patient Prognosis.

Asian Pacific journal of cancer prevention : APJCP·2026

Preoperative Immuno-inflammatory Markers as Predictors of Deep Myometrial Invasion in Endometrial Cancer: A Retrospective Study from Southern Thailand.

Asian Pacific journal of cancer prevention : APJCP·2026

Impact of Prior Biologic Exposure on Upadacitinib Efficacy in Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials.

Cureus·2026

Systemic Evaluation of Administered FITC-Dextran or Evans Blue Dye to Determine Intestinal Barrier Permeability in Nonhuman Primates.

Pathogens & immunity·2026

A four-dimensional framework for classifying functional states in immune cells.

iScience·2026

Related Experiment Videos

Factors predicting the response to rituximab in indolent lymphoma

Related Concept Videos

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma.

Guidelines for composing and assessing a paper on the treatment of pain: A practical application of evidence-based medicine principles to a cost-effectiveness analysis of the MINT randomized clinical trials.

Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro.

Multicompartment imaging of the brain using a comprehensive MR imaging protocol.

Protocol to evaluate the effectiveness of a virtual-reality-based behavioral intervention in enhancing sensory responses to real-world warning.

Evaluation of artificial intelligence-powered screening for sexually transmitted infections-related skin lesions using clinical images and metadata.

Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.

Activity of gallium nitrate in refractory peripheral T-cell lymphoma.

Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.

Long-term follow-up high-dose chemotherapy (drug-only program) followed by autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas.

The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.

Prognosis of follicular lymphomas.

N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population.

Integrated Analysis of the STING1-IRF1 Signaling Pathway and Genomic Alterations in Breast Cancer: Implications for Immune Evasion and Patient Prognosis.

Preoperative Immuno-inflammatory Markers as Predictors of Deep Myometrial Invasion in Endometrial Cancer: A Retrospective Study from Southern Thailand.

Impact of Prior Biologic Exposure on Upadacitinib Efficacy in Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials.

Systemic Evaluation of Administered FITC-Dextran or Evans Blue Dye to Determine Intestinal Barrier Permeability in Nonhuman Primates.

A four-dimensional framework for classifying functional states in immune cells.

Related Experiment Videos

Factors predicting the response to rituximab in indolent lymphoma

Related Concept Videos

Related Articles